Progastrin

Last updated

Progastrin is an 80-amino acid intracellular protein and the precursor of gastrin, a gastrointestinal hormone produced by G cells in the gastric antrum. [1] The main function of gastrin is to regulate acid secretion. [2] During digestion, only gastrin is released into the bloodstream and stimulates the secretion of hydrochloric acid in the stomach as well as pancreatic digestive enzymes. In humans, progastrin is encoded by the GAST [3] gene. Progastrin is expressed primarily in stomach tissue.

Contents

Discovery

In 1905, John Sydney Edkins demonstrated the existence of a hormone responsible for the secretion of gastric acid. [4] This hormone was named gastric secretin or gastrin. But it was not until 1979 and later in 1987 and 1988 that progastrin was identified as the precursor to gastrin. [5] [6] [7] His protein sequence and mRNA were revealed.

Not to be confused with progastrin, Pro-Gastrin-Releasing-Peptide is the precursor of Gastrin-releasing peptide (GRP), a neuropeptide which belongs to the bombesin/neuromedin B family and whose expression is important in the intestine and brain. GRP is involved in many physiological and pathophysiological processes. [8] Gastrin-Releasing Peptide stimulates the release of gastrin and other gastrointestinal hormones. It helps regulate food intake. There are also two types of progastrin, the intracellular progastrin discussed in this article and the extracellular progastrin, mainly called hPG80. [9]

Structure and production

The GAST gene is located on chromosome 17 (17q21). It consists of three exons containing the sequence that encodes preprogastrin. Progastrin is made up of several alpha helices. The primary structure of human preprogastrin consists of a 21 amino acid signal sequence at the N-terminus followed by a spacer peptide, a bioactive domain and finally a C-terminal flanking peptide (CTFP). [10]

Action

The production of gastrin allows the production of gastric acid during food intake to be promoted. Progastrin has also been shown to be expressed in other healthy tissues (cerebellum, pituitary gland, pancreas, testicles), but to a much lesser extent than in the stomach and in different forms. [11] [12] [13] [14] For example, carboxyamide gastrin is found in the testicles. [15] However, the role of progastrin in these organs is not clearly established.

Biosynthesis

In humans, the GAST gene encodes a 101-amino acid precursor peptide, preprogastrin. [16] The latter is synthesized and matured in the endoplasmic reticulum. Upon initiation of translation, the signal sequence facilitating the translocation of the polypeptide is eliminated by a membrane-bound signal peptidase. This enzyme cleaves the born polypeptide chain between alanine residue 21 and serine 22 to generate the 80-amino acid peptide progastrin. The progastrin is then cleaved by an enzyme to give the main circulating biologically active forms of gastrin: gastrin-34 and gastrin-17, in sulfated and unsulfated forms. Both sulfation and phosphorylation play a role in the maturation process: they increase the maturation of progastrin. While phosphorylation can also affect the conversion of intermediate products with carboxy-terminal glycine (G34-Gly and G17-Gly) to mature gastrins. [17] Small amounts of gastrin-52 (also called component 1), gastrin-14 (mini-gastrin) and even smaller fragments were detected in the serum. [18] At this stage, two pathways of post-translational modifications exist within the antral G cells. In the dominant pathway, progastrin is cleaved at three sites, resulting in two major bioactive gastrins, gastrin-34 and gastrin-17. In the putative alternative pathway, progastrin can be cleaved only at the dibasic site closest to the C-terminus, resulting in the synthesis of gastrin-71. [19] The other maturation products, in particular G34-Gly, G17-Gly and CTFP have various functions. CTFP has been described as capable of inducing or inhibiting apoptosis, depending on the tissue or cell type involved. After the progastrin conversion step, there is a passage through the secretory pathway.

Under pathological conditions

As early as 1996, it was demonstrated that the expression of the GAST gene is required for the cellular tumorigenicity of human colorectal cancer. The GAST gene has been shown to be a downstream target of the β-catenin/TCF-4 signalling pathway. Transfection of a construct expressing a constitutively active form of β-catenin triples the activity of the GAST gene promoter. [20] This study establishes a link between progastrin and cancer across many cellular functions involving the Wnt pathway in a cancer cell, starting with its importance for cancer stem cell survival. [21] In pathological situations, progastrin is secreted by tumor cells into the bloodstream and is referred to as hPG80. [22]

The expression of progastrin in many cancers has been demonstrated. [23] It has been noted that in colorectal cancers, progastrin is more than 700 times more abundant than amidated gastrin. [24] Another study showed that colorectal carcinomas have progastrin-derived peptides that are not converted to gastrin. [25] Finally, it has been shown that half of the tumor cells express progastrin. Ovarian, liver and pancreatic cancers present the same scenario: unmatured progastrin is more abundant than amidated gastrin. [26] [27] [28] This is because progastrin is not fully matured and is secreted into the bloodstream for many cancers.

Related Research Articles

<span class="mw-page-title-main">Cholecystokinin</span> Hormone of the gastrointestinal system

Cholecystokinin is a peptide hormone of the gastrointestinal system responsible for stimulating the digestion of fat and protein. Cholecystokinin, formerly called pancreozymin, is synthesized and secreted by enteroendocrine cells in the duodenum, the first segment of the small intestine. Its presence causes the release of digestive enzymes and bile from the pancreas and gallbladder, respectively, and also acts as a hunger suppressant.

<span class="mw-page-title-main">Gastrin</span> Mammalian protein found in Homo sapiens

Gastrin is a peptide hormone that stimulates secretion of gastric acid (HCl) by the parietal cells of the stomach and aids in gastric motility. It is released by G cells in the pyloric antrum of the stomach, duodenum, and the pancreas.

<span class="mw-page-title-main">Gastrin-releasing peptide</span>

Gastrin-releasing peptide, also known as GRP, is a neuropeptide, a regulatory molecule that has been implicated in a number of physiological and pathophysiological processes. Most notably, GRP stimulates the release of gastrin from the G cells of the stomach.

<span class="mw-page-title-main">Neurotensin</span> Chemical compound

Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system. Neurotensin was first isolated from extracts of bovine hypothalamus based on its ability to cause a visible vasodilation in the exposed cutaneous regions of anesthetized rats.

<span class="mw-page-title-main">Enteroendocrine cell</span>

Enteroendocrine cells are specialized cells of the gastrointestinal tract and pancreas with endocrine function. They produce gastrointestinal hormones or peptides in response to various stimuli and release them into the bloodstream for systemic effect, diffuse them as local messengers, or transmit them to the enteric nervous system to activate nervous responses. Enteroendocrine cells of the intestine are the most numerous endocrine cells of the body. They constitute an enteric endocrine system as a subset of the endocrine system just as the enteric nervous system is a subset of the nervous system. In a sense they are known to act as chemoreceptors, initiating digestive actions and detecting harmful substances and initiating protective responses. Enteroendocrine cells are located in the stomach, in the intestine and in the pancreas. Microbiota play key roles in the intestinal immune and metabolic responses in these enteroendocrine cells via their fermentation product, acetate.

<span class="mw-page-title-main">Neuromedin B receptor</span> Protein-coding gene in the species Homo sapiens

The neuromedin B receptor (NMBR), now known as BB1 is a G protein-coupled receptor whose endogenous ligand is neuromedin B. In humans, this protein is encoded by the NMBR gene.

<span class="mw-page-title-main">Gastrin-releasing peptide receptor</span> Protein-coding gene in the species Homo sapiens

The gastrin-releasing peptide receptor (GRPR), now properly known as BB2 is a G protein-coupled receptor whose endogenous ligand is gastrin releasing peptide. In humans it is highly expressed in the pancreas and is also expressed in the stomach, adrenal cortex and brain.

<span class="mw-page-title-main">Cholecystokinin B receptor</span> Protein-coding gene in the species Homo sapiens

The cholecystokinin B receptor also known as CCKBR or CCK2 is a protein that in humans is encoded by the CCKBR gene.

<span class="mw-page-title-main">Somatostatin receptor 2</span> Protein-coding gene in the species Homo sapiens

Somatostatin receptor type 2 is a protein that in humans is encoded by the SSTR2 gene.

<span class="mw-page-title-main">LGR5</span> Protein-coding gene in humans

Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) also known as G-protein coupled receptor 49 (GPR49) or G-protein coupled receptor 67 (GPR67) is a protein that in humans is encoded by the LGR5 gene. It is a member of GPCR class A receptor proteins. R-spondin proteins are the biological ligands of LGR5. LGR5 is expressed across a diverse range of tissue such as in the muscle, placenta, spinal cord and brain and particularly as a biomarker of adult stem cells in certain tissues.

<span class="mw-page-title-main">RhoC</span> Protein-coding gene in the species Homo sapiens

RhoC is a small signaling G protein, and is a member of the Rac subfamily of the family Rho family of GTPases. It is encoded by the gene RHOC.

<span class="mw-page-title-main">SART1</span> Protein-coding gene in the species Homo sapiens

U4/U6.U5 tri-snRNP-associated protein 1 is a protein that in humans is encoded by the SART1 gene. This gene encodes two proteins, the SART1(800) protein expressed in the nucleus of the majority of proliferating cells, and the SART1(259) protein expressed in the cytosol of epithelial cancers. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1(259) protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1(259) antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1(259) protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway.

<span class="mw-page-title-main">TKTL1</span> Mammalian protein found in Homo sapiens

Transketolase-like-1 (TKTL1) is a gene closely related to the transketolase gene (TKT). It emerged in mammals during the course of evolution and, according to the latest research findings, is considered one of the key genes that distinguishes modern humans from Neanderthals.

Mouse models of colorectal cancer and intestinal cancer are experimental systems in which mice are genetically manipulated, fed a modified diet, or challenged with chemicals to develop malignancies in the gastrointestinal tract. These models enable researchers to study the onset, progression of the disease, and understand in depth the molecular events that contribute to the development and spread of colorectal cancer. They also provide a valuable biological system, to simulate human physiological conditions, suitable for testing therapeutics.

<span class="mw-page-title-main">TMEM158</span> Protein-coding gene in the species Homo sapiens

Transmembrane protein 158 is a protein that in humans is encoded by the TMEM158 gene.

mir-143 RNA molecule

In molecular biology mir-143 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms. mir–143 is highly conserved in vertebrates. mir-143 is thought be involved in cardiac morphogenesis but has also been implicated in cancer.

Neuroendocrine differentiation is a term primarily used in relation to prostate cancers that display a significant neuroendocrine cell population on histopathological examination. These types of prostate cancer comprise true neuroendocrine cancers, such as small cell carcinoma, carcinoid and carcinoid-like tumors, as well as prostatic adenocarcinoma exhibiting focal neuroendocrine phenotype.

Hilda Tracy worked at University of Liverpool, UK, with Rod Gregory FRS to isolate and characterise the gastrointestinal hormone gastrin. She led the structure-function studies and had the first insight into gastrin's role in the clinical pathology of pancreatic Zollinger-Ellison tumours.

Pro-Gastrin-Releasing-Peptide, also known as Pro-GRP, is a Gastrin-Releasing-Peptide (GRP) precursor, a neurotransmitter that belongs to the bombesine/neuromedin B family. GRP stimulates the secretion of gastrin in order to increase the acidity of the gastric acid. Pro-GRP is a peptide composed of 125 amino acids, expressed in the nervous system and digestive tract. It is also important to not confused with progastrin, consisting of 80 amino acids, precursor of gastrin in its intracellular version and oncogene in its extracellular version (hPG80).

hPG80 refers to the extracellular and oncogenic version of progastrin. This name first appeared in a scientific publication in January 2020. Until that date, scientific publications only mention 'progastrin', without necessarily explicitly specifying whether it is intracellular or extracellular in the tumor pathological setting.

References

  1. ↑ Fiona M., Gribble; Frank, Reimann; Geoffrey, P. Roberts (2018). Gastrointestinal Hormones. Physiology of the Gastrointestinal Tract, Elsevier. pp. 31–70.
  2. ↑ Rehfeld, Jens F.; Goetze, Jens Peter (2005). "2 The Post-Translational Phase of Gene Expression in Tumor Diagnosis". Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas. Vol. 4. Elsevier. pp. 23–32. doi:10.1016/s1874-5784(05)80057-1. ISBN   978-0-12-369402-7.
  3. ↑ "GAST - Gastrin precursor - Homo sapiens (Human) - GAST gene & protein". www.uniprot.org. Retrieved 2020-06-26.
  4. ↑ Modlin, Irvin M.; Kidd, Mark; Marks, I. N.; Tang, Laura H. (February 1997). "The pivotal role of John S. Edkins in the discovery of gastrin". World Journal of Surgery. 21 (2): 226–34. doi:10.1007/s002689900221. ISSN   0364-2313. PMID   8995084. S2CID   28243696.
  5. ↑ Noyes, B. E.; Mevarech, M.; Stein, R.; Agarwal, K. L. (1979-04-01). "Detection and partial sequence analysis of gastrin mRNA by using an oligodeoxynucleotide probe". Proceedings of the National Academy of Sciences. 76 (4): 1770–4. Bibcode:1979PNAS...76.1770N. doi: 10.1073/pnas.76.4.1770 . ISSN   0027-8424. PMC   383472 . PMID   88048.
  6. ↑ Desmond, H.; Pauwels, S.; Varro, A.; Gregory, H. (1987-01-05). "Isolation and characterization of the intact gastrin precursor from a gastrinoma". FEBS Letters. 210 (2): 185–8. doi: 10.1016/0014-5793(87)81334-0 . PMID   3792562. S2CID   20561440.
  7. ↑ "Announcements". Regulatory Peptides. 34 (1): 71–72. 1991. doi: 10.1016/0167-0115(91)90226-7 . ISSN   0167-0115. S2CID   208789664.
  8. ↑ You, Benoit; Mercier, Frédéric; Assenat, Eric; Langlois-Jacques, Carole; Glehen, Olivier; Soulé, Julien; Payen, Léa; Kepenekian, Vahan; Dupuy, Marie; Belouin, Fanny; Morency, Eric (January 2020). "The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients". EBioMedicine. 51: 102574. doi:10.1016/j.ebiom.2019.11.035. PMC   6938867 . PMID   31877416.
  9. ↑ Benoit You, Frédéric Mercier, Eric Assenat; Alexandre Prieur; Léa Payen, Vahan Kepenekian, Marie Dupuy; Fanny Belouin, Eric Morency (January 2020). "The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients". EBioMedicine. 51: 102574. doi:10.1016/j.ebiom.2019.11.035. PMC   6938867 . PMID   31877416.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  10. ↑ "GAST (gastrin)". atlasgeneticsoncology.org. Retrieved 2020-06-26.
  11. ↑ Schalling, M; Persson, H; Pelto-Huikko, M; Odum, L (1990-08-01). "Expression and localization of gastrin messenger RNA and peptide in spermatogenic cells". Journal of Clinical Investigation. 86 (2): 660–9. doi: 10.1172/JCI114758 . ISSN   0021-9738. PMC   296774 . PMID   2117026.
  12. ↑ Bardram, Linda (1990). "Progastrin in serum from Zollinger-Ellison patients". Gastroenterology. 98 (6): 1420–6. doi:10.1016/0016-5085(90)91071-D. PMID   2338186.
  13. ↑ Rehfeld, J.F. (1991). "Progastrin and its products in the cerebellum". Neuropeptides. 20 (4): 239–45. doi:10.1016/0143-4179(91)90014-A. PMID   1812406. S2CID   21211891.
  14. ↑ Larsson, L.; Rehfeld, J. (1981-08-14). "Pituitary gastrins occur in corticotrophs and melanotrophs". Science. 213 (4509): 768–70. Bibcode:1981Sci...213..768L. doi:10.1126/science.6266012. ISSN   0036-8075. PMID   6266012.
  15. ↑ Zavala‐Pompa, Angel; Ro, Jae Y.; El‐Naggar, Adel; OrdóNtez, Nelson G. (1993). "Primary carcinoid tumor of testis. Immunohistochemical, ultrastructural, and DNA flow cytometric study of three cases with a review of the literature". Cancer. 72 (5): 1726–32. doi: 10.1002/1097-0142(19930901)72:5<1726::aid-cncr2820720536>3.0.co;2-s . ISSN   1097-0142. PMID   7688660.
  16. ↑ "GAST (gastrin)". atlasgeneticsoncology.org. Retrieved 2020-06-26.
  17. ↑ Bishop, L; Dimaline, R; Blackmore, C; Deavall, D (1998). "Modulation of the cleavage of the gastrin precursor by prohormone phosphorylation". Gastroenterology. 115 (5): 1154–62. doi:10.1016/S0016-5085(98)70086-1. PMID   9797370.
  18. ↑ Rehfeld, Jens F.; Goetze, Jens Peter (2005). "2 The Post-Translational Phase of Gene Expression in Tumor Diagnosis". Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas. Vol. 4. Elsevier. pp. 23–32. doi:10.1016/s1874-5784(05)80057-1. ISBN   978-0-12-369402-7.
  19. ↑ "GAST - Gastrin precursor - Homo sapiens (Human) - GAST gene & protein". www.uniprot.org. Retrieved 2020-06-26.
  20. ↑ Koh, Theodore J.; Bulitta, Clemens J.; Fleming, John V.; Dockray, Graham J. (2000-08-15). "Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis". Journal of Clinical Investigation. 106 (4): 533–9. doi:10.1172/JCI9476. ISSN   0021-9738. PMC   380254 . PMID   10953028.
  21. ↑ Prieur, Alexandre; Dominique Joubert, Monica; Habif, Guillaume; Flaceliere, Maud (2017). "Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer". Clinical Cancer Research. 23 (17): 5267–5280. doi: 10.1158/1078-0432.CCR-17-0533 . ISSN   1078-0432. PMID   28600477. S2CID   22085894 . Retrieved 2020-06-23.
  22. ↑ You, Benoit; Mercier, Frédéric; Assenat, Eric; Langlois-Jacques, Carole (2020). "The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients". EBioMedicine. 51: 102574. doi:10.1016/j.ebiom.2019.11.035. PMC   6938867 . PMID   31877416.
  23. ↑ Kochman, Michael Lee; DelValle, John; Dickinson, Chris John; Boland, C.Richard (1992). "Post-translational processing of gastrin in neoplastic human colonic tissues". Biochemical and Biophysical Research Communications. 189 (2): 1165–9. doi:10.1016/0006-291X(92)92326-S. hdl: 2027.42/29682 . PMID   1472026.
  24. ↑ Nemeth, J; Taylor, B; Pauwels, S; Varro, A (1993-01-01). "Identification of progastrin derived peptides in colorectal carcinoma extracts". Gut. 34 (1): 90–5. doi:10.1136/gut.34.1.90. ISSN   0017-5749. PMC   1374107 . PMID   8432459.
  25. ↑ Van Solinge, Wouter W.; Nielsen, Finn C.; Friis-Hansen, Lennart; Falkmer, Ursula G. (1993). "Expression but incomplete maturation of progastrin in colorectal carcinomas". Gastroenterology. 104 (4): 1099–107. doi: 10.1016/0016-5085(93)90279-l . ISSN   0016-5085. PMID   8462798.
  26. ↑ Caplin, Martyn; Khan, Kosser; Savage, Kay; Rode, Jurgen (1999). "Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma". Journal of Hepatology. 30 (3): 519–26. doi:10.1016/S0168-8278(99)80114-7. PMID   10190738.
  27. ↑ Caplin, M.; Savage, K.; Khan, K.; Brett, B. (2000-08-01). "Expression and processing of gastrin in pancreatic adenocarcinoma: Gastrin and pancreatic cancer". British Journal of Surgery. 87 (8): 1035–40. doi:10.1046/j.1365-2168.2000.01488.x. PMID   10931047. S2CID   24292877.
  28. ↑ Singh, P.; Xu, Z.; Dai, B.; Rajaraman, S. (1994-03-01). "Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins". American Journal of Physiology. Gastrointestinal and Liver Physiology. 266 (3): G459-68. doi:10.1152/ajpgi.1994.266.3.G459. ISSN   0193-1857. PMID   8166285.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.